Eudralex Volume 3 CHMP/CAT position statement on Creutzfeldt-Jakob disease and advanced therapy medicinal products
Titel:
Eudralex Volume 3 CHMP/CAT position statement on Creutzfeldt-Jakob disease and advanced therapy medicinal products
Internet:
Herkunft/Verlag:
European Commission Enterprise and Industry DG, BREY 13/ 092, B - 1049 Brussels (Belgium), http://ec.europa.eu/enterprise/
Dokumentenart:
Draft Guideline
Inhalt:
Aktueller Stand der betreffenden Guidelines für Neuartige Therapien